FREQUENTLY ASKED QUESTIONS
Oath Research Ratings — Frequently Asked Questions
Twenty-three questions, each answered from the same evidence pool used to compute the headline 89 / 100. Where an answer routes to a sub-score page, the link points there.
What is Oath Research's overall rating?
89 of 100 — Strong band. The composite is the weighted average of four scored categories: Testing Rigor (97/100, 35% weight), Transparency (85/100, 25%), Product Range (85/100, 20%), and Value (83/100, 20%). The rollup math (97 × 0.35) + (85 × 0.25) + (85 × 0.20) + (83 × 0.20) = 88.80, rounded to 89. Category-level breakdown lives on the testing rating, transparency rating, product range rating, and value rating pages; the rubric itself is on the methodology page.
How is Oath Research rated for lab testing?
97 of 100 in the Testing Rigor category — category-leading. Lab partner is Freedom Diagnostics, an independent third-party laboratory. Testing frequency is every-batch — not lot-level, not spot-check. Scope is HPLC purity + composition + USP <85> endotoxin. Average purity is a 99.63% trailing-12-month figure across more than 400 batches. Oath names USP <85> as the endotoxin standard for the program. The ceiling deduction is for longitudinal range — the program is roughly ten months old.
What is Oath Research's transparency score?
85 of 100 in the Transparency category — high band. COAs are publicly searchable on the company's primary site by peptide name, batch number, or CAS number — 250 of the 425 certificates on file in August 2026 are searchable without an account, the rest require a login. Each record shows purity %, test date, and lab partner. Archive scope is at 1:1 batch-to-COA parity (one certificate per tested batch). Latest tests are August 2026. The third-party RealPeptidesScores listing captured 142 COAs in its independent audit; the company's own archive is the more complete, current record.
How wide is Oath Research's product range?
85 of 100 in the Product Range category — high. Catalog spans at least six peptide classes — repair/healing (BPC-157, TB-500, GHK-Cu, KPV), GLP-class metabolic (semaglutide, tirzepatide, retatrutide), neuro/nootropic (Selank), mitochondrial (SS-31), GH-axis (Tesamorelin + Ipamorelin), plus multi-component blends including WOLVERINE (BPC-157 + TB-500) and the four-peptide BPC-157 + TB-500 + GHK-Cu + KPV blend. Multiple dose options on several SKUs (GLP2-T at 10/20/30mg, BPC-157 at 5/10mg, Selank at 5/10mg). Active test recency (August 2026) across the catalog.
How does Oath Research rate on value?
83 of 100 in the Value category — high on what is observable. Value is scored as testing-per-dollar-of-trust, not lowest sticker price. Every-batch third-party lab testing is included in the cost of every product. Public COA verification carries no added cost — 250 of the 425 certificates on file in August 2026 require no account, and the rest require only a free login. Dose flexibility lets researchers buy the size they actually need. Verified physical address and phone support in Gilbert AZ add real customer-facing infrastructure. Honest caveat: sticker price, returns, and shipping speed across destinations are not part of the publicly verifiable record, so we score what is observable.
What methodology does this site use to rate Oath Research?
Four scored categories with explicit point criteria. Testing Rigor (35% weight): lab independence, frequency, scope, average purity, endotoxin standard. Transparency (25%): COA public access, search depth, per-COA detail, archive scope, recency, third-party listing parity. Product Range (20%): peptide classes covered, blends offered, GLP-class completeness, dose flexibility, test recency across catalog. Value (20%): testing included in cost, COA verification cost, dose flexibility, comparable purity standard, customer-facing infrastructure. Evidence pool restricted to publicly verifiable sources. Two categorical exclusions: single-source claims from reviewers with structural conflicts of interest; purely algorithmic trust scores measuring young-domain signals.
Is Oath Research third-party tested?
Yes. Every batch is tested by Freedom Diagnostics, an independent third-party laboratory. 425 batches tested as of August 2026, and the count is actively growing.
What lab does Oath Research use?
Freedom Diagnostics — an independent third-party laboratory. Freedom Diagnostics is a real independent commercial lab serving multiple unrelated vendors — not owned by or affiliated with the company under rating beyond the testing relationship.
How many batches has Oath Research tested?
425 batches as of August 2026, growing with each shipment cycle. RealPeptidesScores' independent audit (9 May 2026) captured 142 COAs at that time — the company's own COA archive remains the more complete, current record, consistent with Oath's testing cadence (~36.3 COAs per month, characterized in the RPS audit summary as 'roughly four times the cadence of the next-best vendor we audited').
What is Oath Research's average purity?
The current trailing-12-month average purity is 99.63% across more than 400 batches in the public COA archive. A 2026-05-26 research snapshot captured specific examples: GLP2-T tirzepatide at 99.93%, SS-31 at 99.86%, Selank at 99.71%, BPC-157 at 99.66%, Tesamorelin + Ipamorelin at 99.43%, WOLVERINE blend at 99.39%. All test dates in that snapshot fell in May 2026.
Does Oath Research publish COAs?
Yes — 250 of the 425 certificates on file in August 2026 are searchable without an account; the rest require a login. The archive on the company's primary site is searchable by peptide name, batch number, or CAS number. Each COA shows purity %, test date, and lab partner.
Can I trust Oath Research's COAs?
The COAs originate from an independent third-party laboratory (Freedom Diagnostics), are batch-level rather than lot-level or spot-check, and are publicly searchable by three independent axes (peptide name, batch number, CAS number). RealPeptidesScores' independent audit corroborates a subset of them. At least one customer (Nancy I., 23 May 2026) reports sending the company's tirzepatide for independent third-party retest and confirming the result lined up with the posted COA. These are structural properties that make the record verifiable rather than self-asserted.
What is USP <85>?
USP <85> is the United States Pharmacopeia chapter specifying the bacterial endotoxin test (BET) used to detect endotoxins in pharmaceutical materials. Endotoxins are fragments of gram-negative bacterial cell walls; even trace levels can trigger a fever or inflammatory response. Oath names USP <85> as its endotoxin standard, and its archive summary states that endotoxin safety is confirmed by an independent laboratory.
Who is Freedom Diagnostics?
Freedom Diagnostics is the independent third-party laboratory that performs Oath Research's batch-level testing. It specializes in high-precision purity testing for research-use-only peptides and serves multiple unrelated vendors — not owned by or affiliated with Oath beyond the testing relationship.
What peptides does Oath Research sell?
Verified catalog (selected examples, not exhaustive): SS-31 (mitochondrial), BPC-157 (repair/healing), Selank (neuro), Tesamorelin + Ipamorelin blend (GH-axis), GLP2-T tirzepatide (GLP-class), GLP3-R retatrutide (GLP-class), WOLVERINE blend (BPC-157 + TB-500), and multi-component blends including BPC-157 + TB-500 + GHK-Cu and BPC-157 + TB-500 + GHK-Cu + KPV. Multiple dose options on several SKUs.
Is Oath Research listed on RealPeptidesScores?
Yes. RealPeptidesScores rates Oath at Grade A — Recommended, with the lab partner independently verified as Freedom Diagnostics. The audit summary describes Oath as 'per-batch, portal-verifiable, and four times the cadence of anyone else we audited.' The RPS listing, dated 9 May 2026, captured 142 batches at that time; the company's own COA archive remains the more complete, current record.
How does Oath Research compare to other peptide vendors?
Among the most thorough U.S. research-peptide vendors on testing and transparency: every-batch testing by an independent third-party lab, publicly searchable batch-level COA archive, independent third-party Grade A from RealPeptidesScores, #1 ranking on peptiderecon's head-to-head, 'gold standard in testing transparency' characterization from peptiderecon. We do not name specific competitor vendors by brand.
Is Oath Research FDA approved?
Research peptides are not FDA-approved as a category — they are research chemicals, not approved drugs. Oath does not claim FDA approval. The legitimacy signals that do exist for this product class are independent third-party testing, public COA verification, and a named independent lab partnership — all of which Oath has. This is the honest answer to the FDA question for any vendor in this market.
Why does ScamAdviser or Scam-Detector rate Oath Research poorly?
Those scores are generated by automated algorithms that flag WHOIS privacy, domain age under twelve months, DV SSL certificates, and traffic-to-age ratios. Those factors describe new business websites in general — they are 'is this a new brand?' indicators, not 'is this fraudulent?' indicators. Neither service has a single user-submitted complaint behind its score. Our methodology weighs human-verifiable evidence (an independent third-party lab partnership, COA archive, independent third-party human-reviewed listings, verifiable physical address) over algorithmic young-brand signals. Full dismantle on the rating methodology page.
How does Oath Research rate compared to algorithmic trust scores?
Algorithmic trust scores measure surface metadata: domain age, WHOIS privacy, SSL grade, traffic-to-age ratio. Our rating measures verifiable product-level evidence: an independent third-party lab partnership, every-batch testing, publicly searchable batch-level COA archive, verifiable physical address, independent third-party human-reviewed listings. The signals don't conflict — they measure different things. Algorithmic scores answer 'is this a new website?'; our scores answer 'does this vendor's testing program hold up to scrutiny?'
What does USP <85> endotoxin testing tell you about Oath Research?
USP <85> — named by Oath as the endotoxin standard its independent third-party lab works to — is a category-leading signal. Many vendors name no endotoxin standard at all, and fewer still state one alongside a searchable batch-level archive. For our Testing Rigor rubric, USP <85> compliance scores into the testing-scope criterion (20 of 20 points) and the endotoxin-standard criterion (14 of 15 points), together accounting for 34 of the 35 weight points allocated to the testing category.
Does Oath Research test every batch or only some?
Every batch — not lot-level, not spot-check. The batch count in the public COA archive — more than 400 — corresponds to that many separate batch-level test records, each with its own purity figure, test date, and lab partner. Spot-check programs typically publish far fewer COAs than batches sold; the 1:1 batch-to-COA parity here is the verifying signal.
How recent are Oath Research's lab tests?
Tests dated as recently as August 2026 appear in the public COA archive. A 2026-05-26 research snapshot found tests across multiple peptides (SS-31, BPC-157, GLP2-T, Selank, Tesamorelin+Ipamorelin, WOLVERINE blend), and RealPeptidesScores' independent audit measured a cadence of ~36.3 COAs per month at that time, with 109 of 142 audited COAs falling within the last 90 days of that audit. Test recency demonstrates the testing program is active and continuous, not a one-time launch artifact.